PacBio announced a key study published in the American Journal of Human Genetics by Radboud University Medical Center, showcasing the effectiveness of its HiFi long-read sequencing technology for ...

PacBio announced the early shipment of its Vega benchtop sequencing system and the launch of SPRQ chemistry, enabling affordable HiFi genome sequencing for under $500 on the Revio system. Despite ...

PACB launched SPRQ-Nx and multi-use SMRT Cells for Revio, lowering sequencing costs by about 30%. PacBio says SPRQ-Nx can push human genome sequencing costs below $300 at scale. PACB upgraded ...

PACB launched a joint FFPE workflow with Covaris to improve the sequencing of archived tumor samples. The solution enhances DNA recovery, boosting structural variant detection and mutation phasing ...

MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...

MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally ...

Recent advancements in single-molecule, long-read sequencing (LRS) technologies, developed by companies such as Oxford Nanopore Technologies (ONT) and Pacific Biosciences (PacBio), have substantially ...

Ark Invest CEO Cathie Wood is doubling down on genomics. What Happened: Pacific Biosciences of California Inc. (NASDAQ:PACB), known as PacBio, is biotech’s new kid on the block. The company's Vega ...

Pacific Biosciences of California Inc. (NASDAQ:PACB) on Wednesday announced preliminary revenue of $36.9 million versus a consensus of $33.49 million. The company said the first quarter met ...

Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) in San Diego have successfully applied long-read genome sequencing to reveal the genetic underpinnings of complex psychiatric ...